Month: May 2013

Computer Sciences Corp ( CSC ) is set to dispose of its Applied Technology Division (ATD), which deals with base operation, range service and aviation services, to PAE for a sum of $175.0 million in cash. This is the sixth continuous divesture that the company made over a period of seven months. This reiterates the fact that CSC is committed on rebalancing the company’s portfolio in a way, which will help them strengthen the company’s business model by focussing on core strength of the company. […]

Anacor Pharmaceuticals, Inc. ( ANAC ) recently held a pre-NDA (New Drug Application) meeting with the US Food and Drug Administration (FDA) for its anti- fungal onychomycosis candidate, tavaborole (AN2690). During interactions with the FDA, Anacor came to an agreement regarding the content and format of the proposed NDA for tavaborole […]

NavCom Technology, Inc., a unit of Deere & Company ( DE ), has introduced new software for its Sapphire-based receivers. The software including the SF-3050, SF-3040, and LAND-PAK will help customers to improve productivity. The multi-frequency GNSS (Global Navigation Satellite System) receivers are now able to support NavCom’s new StarFire Rapid Recovery feature […]

Bayer ( BAYRY ) recently received antitrust clearance from the US Federal Trade Commission (FTC) with respect to the acquisition of Conceptus Inc. ( CPTS ). The FTC did not raise any objection with respect to the deal within the relevant waiting period under the US antitrust law […]

General Dynamics Corporation ’s ( GD ) business division General Dynamics Land Systems is working on the development of the first North American combat vehicle equipped with an Active Protection System ("APS"). The APS feature boosts crew protection, survivability and provides situational awareness by intercepting and beating threats against man-portable weapons before reaching the vehicle. […]

Roche Holding AG ( RHHBY ) recently announced that the company has launched the subcutaneous injection formulation of its rheumatoid arthritis (RA) drug Actemra in Japan. The subcutaneous version of the drug was approved for treating RA patients who do not respond adequately to one or more existing therapies. […]

As a part of its re-franchising initiative, Jack in the Box Inc. ( JACK ) recently completed re-franchising of its 22 company-owned restaurants to two franchisees, Ameen Poonja and TLIG Restaurants, LLC. The financial terms of the transaction were not disclosed […]

Accenture plc ( ACN ) has been selected by the electricity and gas company, SSE plc, to improve their customer offer and field force under SSE’s Retail Transformation Program. This program focuses on improving the company’s retail business and meeting government prerequisites for rolling out in excess of nine million smart meters by 2019. Accenture and SSE will work together under the multi-year, multi-million dollar contract for implementing a customer campaign management solution under SSE’s Domestic Customer project (DC) and a field force productivity solution for its Metering Transformation Project (MTP) […]

The US Food and Drug Administration (FDA) recently granted orphan drug designation to Astellas Pharma, Inc. ’s ( ALPMY ) invasive aspergillosis candidate, isavuconazole. Isavuconazole is an azole antifungal agent, jointly developed by Basilea Pharmaceuticals AG and Astellas […]

On May 29, 2013, the shares of FleetCor Technologies, Inc. ( FLT ) reached a new 52-week high of $87.45. The momentum was driven by the company’s strong first-quarter earnings […]

Japan’s SoftBank Corp., which plans to take over Sprint Nextel Corp. ( S ), the third-largest wireless carrier in the U.S., cleared a major hurdle by reaching an agreement with the U.S. government officials regarding the country’s security matters […]

On May 28, 2013, we maintained our long-term recommendation on JPMorgan Chase & Co. ( JPM ) at Neutral. The reiteration was based on the company’s strong first-quarter results, which significantly surpassed the Zacks Consensus Estimate […]